HIGHLIGHTS
- who: Melody Hermel and colleagues from the United Medical Doctors, La Jolla, CA, USA Department of Psychology, College of Arts and Sciences, Undergraduate, Georgetown University have published the research work: Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemiau2014The Future Is Here, in the Journal: Pharmaceutics 2023, 15, 459. of /2023/
- what: Undertreatment of elevated lipids persists despite existing therapies. the authors provide an update on therapies and techniques for management of current era of cutting-edge pharmaceuticals targeting low density lipoprotein cholesterol PCSK9 lipoprotein (a) angiopoietin-like 3 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.